JPRN-UMIN000008235招募中1 期
A gene therapy clinical trial for chronic granulomatous disease targeting the patient's hematopoietic stem cells - Gene therapy for chronic granulomatous disease
ational Center for Child Heath and Development0 个研究点目标入组 5 人开始时间: 2012年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Severe cardiorespiratory failure positive for HIV severe allegy no anticipation for long-term live survival
研究者
相似试验
尚未招募
不适用
Lentiviral Gene Therapy for CGDChronic Granulomatous DiseaseNCT03645486Shenzhen Geno-Immune Medical Institute10
招募中
3 期
ncontrol trial of targeted therapy on chronic glomerulonephritischronic glomerulonephritisJPRN-UMIN000006080Department of Cardiorenal Medicine, Yokohama City University School of Medicine25
已完成
1 期
Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-upCommunicable DiseaseChronic Granulomatous DiseaseNCT00001476National Institute of Allergy and Infectious Diseases (NIAID)14
进行中（未招募）
1 期
Phase I/II ex vivo gene therapy clinical trial for RDEB using autologous skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector - EBGraftThe trial aims to treat the recessive dystrophic epidermolysis bullosa (RDEB) by grafting one to three subjects with RDEB with autologous COL7A1-modified skin equivalents, using SIN-RV encoding COL7A1 cDNA.MedDRA version: 20.0 Level: LLT Classification code 10074980 Term: Epidermolysis bullosa aquisita System Organ Class: 100000004858EUCTR2016-002790-35-FRINSERM3
招募中
1 期
Clinical Research of gene therapy for relapsed or refractory B-cell Non-Hodgkin Lymphoma using autologous T cells expressing a chimeric antigen receptor specific to the CD19 antigeRelapsed/Refractory CD19+ B-NHJPRN-UMIN000015617Jichi Medical University18